Valeo Financial Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
Other funds holding TARS
Valeo Financial Advisors's TARS Position: Q3 2026 in Review
Valeo Financial Advisors increased its Tarsus Pharmaceuticals (TARS) stake by 0.34% in Q3 2026, buying an estimated $903 and bringing the position to 3,851 shares worth $303K. The position accounts for 0.01% of the portfolio, ranked #627.
Valeo Financial Advisors first reported a position in TARS in Q3 2025 and has held it in 5 quarters since. The position peaked at $321K in Q4 2025. 254 funds tracked by Wall St. Rank hold TARS as of Q3 2026.
- Valeo Financial Advisors held 3,851 shares of Tarsus Pharmaceuticals worth $303K as of Q3 2026.
- Valeo Financial Advisors bought 13 Tarsus Pharmaceuticals shares in Q3 2026, an estimated $903.
- Tarsus Pharmaceuticals made up 0.01% of Valeo Financial Advisors's portfolio in Q3 2026, its #627 holding.
- Valeo Financial Advisors first reported a position in Tarsus Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
- Valeo Financial Advisors's Tarsus Pharmaceuticals position peaked at $321K in Q4 2025.
- 254 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.
Based on Valeo Financial Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.